(2024)
Unique target binding by the C-terminal Region of FHR1 provides a new perception of aHUS Pathology.
Front Hematol 3,
Christine Skerka
AlumniPublications
(2023)
Increased plasma level of terminal complement complex in AMD patients: potential functional consequences for RPE cells.
Front Immunol 14,
1200725.
(2022)
Candida albicans induces cross-kingdom miRNA trafficking in human monocytes to promote fungal growth.
mBio 13(1),
e0356321.
(2022)
Low molecular weight polysialic acid binds to properdin and reduces the activity of the alternative complement pathway.
Sci Rep 12(1),
5818.
(2022)
Novel FHR2 variants in atypical haemolytic uremic syndrome: a case study of translational medicine approach in renal transplantation.
Front Immunol 13,
1008294.
(2022)
From magic bullets to modern therapeutics: Paul Ehrlich, the German immunobiologist and physician who coined the term ‘Complement’.
Mol Immunol 150,
90-98.
(Review)
(2021)
The protease SplB of Staphylococcus aureus targets host complement components and inhibits complement-mediated bacterial opsonophagocytosis.
J Bacteriol 204(1),
e0018421.
(2021)
Molecular analyses identifies new domains and structural differences among Streptococcus pneumoniae immune evasion proteins PspC and Hic.
Sci Rep 11(1),
1701.
(2021)
Factor H-related protein 1 (FHR-1) is associated with atherosclerotic cardiovascular disease.
Sci Rep 11(1),
22511.
(2021)
Complement catalyzing glomerular diseases.
Cell Tissue Res 385(2),
355-370.
(Review)